27 septiembre 2015
Results from a multi-center randomized international trial of an innovative treatment show a marked improvement in the length of time patients with mid-gut neuroendocrine tumors live without the disease getting worse.
http://www.sciencedaily.com/releases/2015/09/150927115516.htm
